Jiuzhitang Co., Ltd.

000989

CNE000001394

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
8.53 ^CNY	-2.74%		-0.81%	-15.71%

Apr. 02	Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	CI
Mar. 18	Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	CI

Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021 Payable on 01 June 2022

May 26, 2022 at 03:57 pm EDT

Jiuzhitang Co., Ltd. announced final Cash dividend implementation for 2021 per 10 shares (tax included) of CNY 4.00000000. Record date is 31 May 2022, Ex-date is 01 June 2022 and Payment date is 01 June 2022.

Latest news about Jiuzhitang Co., Ltd.

Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	Apr. 02	CI
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Mar. 18	CI
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	Mar. 17	CI
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	Nov. 02	MT
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-07	CI
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	23-06-12	MT
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	23-05-30	CI
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-25	CI
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	23-05-04	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	23-01-11	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22-09-22	MT
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	22-08-17	CI
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021 Payable on 01 June 2022	22-05-26	CI
Yifeng Pharmacy Chain Co., Ltd. completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd..	22-05-25	CI
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021	22-05-23	CI
Jiuzhitang Co., Ltd. Proposes Profit Distribution for 2021	22-04-25	CI
Yifeng Pharmacy Chain Co., Ltd. agreed to acquire 5% stake in Jiuzhitang Co., Ltd. from Li Zhenguo for CNY 430 million.	22-04-24	CI
Yifeng Pharmacy Chain Co., Ltd. agreed to acquire 51% of stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd. for approximately CNY 200 million.	22-04-24	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-21	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-21	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-24	CI

Chart Jiuzhitang Co., Ltd.

Duration

Period

More charts

Company Profile

JIUZHITANG CO.,Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The Company provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Companyâs main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The Company distributes its products in domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
JIUZHITANG CO., LTD.	-15.71%	1.01B
DONG-E-E-JIAO CO.,LTD.	+37.37%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.69%	4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.12%	3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.47%	2.61B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.06%	1.81B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.84%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.60%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.03%	1.55B